Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer

Condition: Ovarian cancer

Category: Cancer,_womenshealth

Type: Article

Date: May 2013

Author: Ian S Zagon

The preclinical data in this study support the transition of LDN and these other novel therapies for treatment of human ovarian cancer from the bench to bedside to provide additional targets for treatment of Ovarian cancer.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.